Zymeworks BC Inc’s filing revealed that its Director EcoR1 Capital, LLC acquired Company’s shares for reported $1.44 million on Mar 18 ’25. In the deal valued at $12.65 per share,113,880 shares were bought. As a result of this transaction, EcoR1 Capital, LLC now holds 16,972,298 shares worth roughly $215.89 million.
Then, EcoR1 Capital, LLC bought 58,306 shares, generating $737,233 in total proceeds. Upon buying the shares at $12.64, the Director now owns 17,030,604 shares.
Before that, EcoR1 Capital, LLC bought 56,277 shares. Zymeworks BC Inc shares valued at $688,465 were divested by the Director at a price of $12.23 per share. As a result of the transaction, EcoR1 Capital, LLC now holds 16,858,418 shares, worth roughly $214.44 million.
JP Morgan upgraded its Zymeworks BC Inc [ZYME] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early November from “a Market perform” to “an Outperform”. Wells Fargo also remained covering ZYME and has decreased its forecast on November 01, 2024 with a “an Equal weight” recommendation from previously “an Overweight” rating.
Price Performance Review of ZYME
On Friday, Zymeworks BC Inc [NASDAQ:ZYME] saw its stock fall -1.62% to $12.72. Over the last five days, the stock has gained 3.84%. Zymeworks BC Inc shares have fallen nearly -13.11% since the year began. Nevertheless, the stocks have risen 20.80% over the past one year. While a 52-week high of $17.70 was reached on 01/03/25, a 52-week low of $7.97 was recorded on 03/11/25. SMA at 50 days reached $13.69, while 200 days put it at $12.46.
Levels Of Support And Resistance For ZYME Stock
The 24-hour chart illustrates a support level at 12.56, which if violated will result in even more drops to 12.41. On the upside, there is a resistance level at 12.95. A further resistance level may holdings at 13.19. The Relative Strength Index (RSI) on the 14-day chart is 47.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.72%. Stochastics %K at 75.04% indicates the stock is a holding.
How much short interest is there in Zymeworks BC Inc?
A steep rise in short interest was recorded in Zymeworks BC Inc stocks on 2025-02-28, dropping by -0.42 million shares to a total of 3.96 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 4.38 million shares. There was a decline of -10.52%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 04, 2023 when H.C. Wainwright resumed its ‘”a Neutral”‘ rating for the stock and retained the price target to $8.
